Title : Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma.

Pub. Date : 2001 Nov 1

PMID : 11745278






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a retrospective subgroup analysis, anastrozole was superior to tamoxifen with respect to TTP (median values of 10.7 and 6.4 months for anastrozole and tamoxifen, respectively, two-sided P = 0.022) in patients with estrogen and/or progesterone receptor positive tumors (60% of combined trial population). Anastrozole progesterone receptor Homo sapiens